OBJECTIVE: The study quantified the side effects of nasal masks use for noninvasive positive pressure ventilation (NPPV) in children. DESIGN AND SETTING: Cross-sectional retrospective study in a tertiary pediatric university hospital. PATIENTS: Patients with obstructive sleep apnea (n=16), neuromuscular disorders (n=14), and cystic fibrosis (n=10). INTERVENTIONS: Clinical evaluation of facial tolerance. MEASUREMENTS AND RESULTS: A skin injury was observed in 19 patients (48%), with a transient erythema in 7 (18%), prolonged erythema in 9 (23%), and skin necrosis in 3 (8%). Skin injury was associated with age over 10 years (OR=16) and use of a commercial mask (OR=15) and was less frequent in patients with obstructive sleep apnea. The change of a commercial mask for a custom-made mask was associated with reduction in the skin injury score. Global facial flattening was present in 68% of the patients. No correlation was observed with age, daily or cumulative use of NPPV, or the type of mask. A maxillary retrusion was present in 37% of patients. No correlation was observed with age or the type of mask or the underlying disease, but an association was found with a longer daily use of NPPV (OR=6.3). CONCLUSIONS: The prevalence of facial side effects is clinically significant in children using NPPV. Systematic maxillofacial follow-up enables these effects to be identified. Remedial measures could include the change of the interface or reducing the daily use of NPPV.
OBJECTIVE: The study quantified the side effects of nasal masks use for noninvasive positive pressure ventilation (NPPV) in children. DESIGN AND SETTING: Cross-sectional retrospective study in a tertiary pediatric university hospital. PATIENTS: Patients with obstructive sleep apnea (n=16), neuromuscular disorders (n=14), and cystic fibrosis (n=10). INTERVENTIONS: Clinical evaluation of facial tolerance. MEASUREMENTS AND RESULTS: A skin injury was observed in 19 patients (48%), with a transient erythema in 7 (18%), prolonged erythema in 9 (23%), and skin necrosis in 3 (8%). Skin injury was associated with age over 10 years (OR=16) and use of a commercial mask (OR=15) and was less frequent in patients with obstructive sleep apnea. The change of a commercial mask for a custom-made mask was associated with reduction in the skin injury score. Global facial flattening was present in 68% of the patients. No correlation was observed with age, daily or cumulative use of NPPV, or the type of mask. A maxillary retrusion was present in 37% of patients. No correlation was observed with age or the type of mask or the underlying disease, but an association was found with a longer daily use of NPPV (OR=6.3). CONCLUSIONS: The prevalence of facial side effects is clinically significant in children using NPPV. Systematic maxillofacial follow-up enables these effects to be identified. Remedial measures could include the change of the interface or reducing the daily use of NPPV.
Authors: Maria Pia Villa; Jacopo Pagani; Rosa Ambrosio; Roberto Ronchetti; Edoardo Bernkopf Journal: Am J Respir Crit Care Med Date: 2002-10-15 Impact factor: 21.405
Authors: B Fauroux; J Pigeot; M I Polkey; G Roger; M Boulé; A Clément; F Lofaso Journal: Am J Respir Crit Care Med Date: 2001-11-15 Impact factor: 21.405
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-18 Impact factor: 17.440
Authors: Richard B Berry; Alejandro Chediak; Lee K Brown; Jonathan Finder; David Gozal; Conrad Iber; Clete A Kushida; Timothy Morgenthaler; James A Rowley; Sally L Davidson-Ward Journal: J Clin Sleep Med Date: 2010-10-15 Impact factor: 4.062
Authors: Christopher M Cielo; Patricia Hernandez; Alyssa M Ciampaglia; Melissa S Xanthopoulos; Suzanne E Beck; Ignacio E Tapia Journal: Chest Date: 2020-08-15 Impact factor: 9.410